THC Farmaceuticals, Inc. (OTCQB:CBDG): today announcedthat Ed Rosenthal, a noted horticulturist, author and publisher is joining CBDGas President of the Company, officially taking up his duties June 15th,2015. Mr. Rosenthal has also agreed to serve as a director of CBDG uponappointment.
Rosenthal is anoted researcher and writer who has specialized in marijuana studies for morethan 35 years. One of his discoveries was identifying terpenes as importantcomponents of marijuana, which he chronicled in his work “Big Book of Buds Vol.3”. Properties of the marijuana plant includes the psychoactive THC, themedically promising cannabinoids (CBD’s) and Terpenes, whose cumulative effectwas later identified by Dr. Raphael Mechoulum, Dean of marijuana researchers,as “The Entourage Effect”.
Rosenthalplans to lead a team of researchers in developing targeted intermediaryphytochemical combinations that can be used in production of both cannabinoidand non-cannabinoid based products.
Rosenthalestimates that the first products based on this research will complete trialwithin six months and will be on store shelves within a year. He stated,“I appreciate the opportunity to lead this research program to develop new andbetter plant based medicines”
This inclusion of Ed Rosenthal to THC Farmaceuticalsbrings to the company the knowledge base of one of the cannabis industries’foremost horticulturist and activists. As an industry leader and cannabisexpert, Mr. Rosenthal will help guide the company’s expansion into cannabis andcannabis related business.
Chief Executive Officer and Former US Senator Mike Gravelstated, “Ed is incredibly knowledgeable; his experience in and connectionwith the cannabis industry is unparalleled. We already had lofty expectationsat THC Farmaceuticals and we’re happy to have secured Rosenthal’sservices and are looking forward to working closely with the research team heis assembling. This team will create a new genre of cannabinoid medicinals thatwill offer patients more choice of effective treatments. With the addition of Ed Rosenthal, we now have ‘high’expectations”
About THC Farmaceuticals, Inc.: CBDG owns and operatesATMs placed in high-traffic commercial areas in Utah and CBDG is now expandingits operations to include businesses and intellectual properties related to thehemp and cannabis industries.
For additional information, contact Eric Miller at (480)725-9060.
Forward-Looking Statements:
This press release contains "forward-lookingstatements." Although the forward-looking statements in this releasereflect the good faith judgment of management, forward-looking statements areinherently subject to known and unknown risks and uncertainties that may causeactual results to be materially different from those discussed in theseforward-looking statements. Readers are urged to carefully review and considerthe various disclosures made by us in our reports filed with the Securities andExchange Commission, including the risk factors that attempt to adviseinterested parties of the risks that may affect our business, financialcondition, results of operation and cash flows. If one or more of these risksor uncertainties materialize, or if the underlying assumptions prove incorrect,our actual results may vary materially from those expected or projected.Readers are urged not to place undue reliance on these forward-lookingstatements, which speak only as of the date of this release. We assume noobligation to update any forward-looking statements in order to reflect anyevent or circumstance that may arise after the date of this release.
Copyright © 2015 OTC Markets. All Rights Reserved
The above news release has been provided by the above companyvia the OTC Disclosure and News Service. Issuers of news releases and not OTCMarkets Group Inc. are solely responsible for the accuracy of such newsreleases.